A man has been awarded $1.75 million by a jury that determined his breast growth was caused by his use of Risperdal as a child. This is the fourth trial involving the link between Risperdal and male breast growth. The first two also resulted in decisions favoring the plaintiffs and the... Read more »

GlaxoSmithKline has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federal Zofran lawsuits for coordinated pretrial proceedings. As the number of product liability lawsuits filed on behalf of children born with heart defects, cleft palate and other congenital defects allegedly caused by exposure... Read more »

A Risperdal lawsuit that was pending in a Philadelphia court resulted in a mixed outcome for the plaintiff. The 19-year-old man filed the lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, claiming that the defendants’ medication resulted in the abnormal growth of breast tissue. On Friday, March 20, the... Read more »

A mother of two young children has filed a Zofran lawsuit against GlaxoSmithKline (GSK) alleging that the anti-nausea medication led to both of her children’s serious health problems. The Minnesota mother filed her lawsuit on behalf of herself and her minor children in the U.S. District Court for the Eastern... Read more »

A Philadelphia law firm has filed a Risperdal lawsuit against the Department of Health and Human Services and the Food and Drug Administration. The firm represents hundreds of children who have been allegedly injured as a result of ingesting Risperdal. The antipsychotic drug is used to treat a variety of mental/mood... Read more »

Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas recently issued an order that has created a mass tort docket for Xarelto lawsuits filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals. The January 21, 2015 order affects at least 75 cases that share common allegations regarding the medication,... Read more »

Families who are suing Zoloft manufacturer Pfizer based on allegations that the SSRI caused birth defects in their children have been granted a second chance to present an expert witness, according to a recent ruling by Judge Cynthia M. Rufe. The plaintiffs’ Zoloft birth defects lawsuits have been centralized for... Read more »

As the wave of lawsuits involving antipsychotic drug Risperdal continues to gain momentum, several key cases are slated for trial in the coming months in Pennsylvania state court. These suits involve allegations made on behalf of males who suffered excessive breast development after taking the medication in their youth. Johnson &... Read more »

Earlier this month, a 79-year-old Philadelphia woman received a $2 million Actos lawsuit award for her bladder cancer claim. The jurors, after deliberating for more than five hours, found that the manufacturer was liable for Frances Wisniewski’s bladder cancer because it failed to warn her doctors about the cancer risk.... Read more »

The atypical antipsychotic Risperdal continues to fuel litigation, as scores of male patients claim they developed breasts after taking the drug as children and adolescents. Court dockets indicate some 500 Risperdal lawsuits pending against pharmaceutical giant Johnson & Johnson, which has already settled a handful of claims (under confidential terms)... Read more »